Emerging pro-drug and nano-drug strategies for gemcitabine-based cancer therapy.

Han, Haijie; Li, Su; Zhong, Yueyang; Huang, Yue; Wang, Kai; Jin, Qiao; Ji, Jian; Yao, Ke.

Afiliação

Han H; Eye Center, the Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310009, China.
Li S; Zhejiang Provincial Key Lab of Ophthalmology, the Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310009, China.
Zhong Y; MOE Key Laboratory of Macromolecule Synthesis and Functionalization of Ministry of Education, Department of Polymer Science and Engineering, Zhejiang University, Hangzhou 310027, China.
Huang Y; Eye Center, the Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310009, China.
Wang K; Zhejiang Provincial Key Lab of Ophthalmology, the Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310009, China.
Jin Q; Eye Center, the Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310009, China.
Ji J; Zhejiang Provincial Key Lab of Ophthalmology, the Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310009, China.
Yao K; MOE Key Laboratory of Macromolecule Synthesis and Functionalization of Ministry of Education, Department of Polymer Science and Engineering, Zhejiang University, Hangzhou 310027, China.

Asian J Pharm Sci ; 17(1): 35-52, 2022 Jan.

Article em En | MEDLINE | ID: mdl-35261643